Fosun Pharma Purchases Another $35 Million of Simcere Pharmaceutical Group's Stock  
3/26/2012 8:17:07 AM

March 23, 2012 -- Fosun Pharma has bought another slice of Simcere Pharma, paying $35 million on the open market for slightly less than a 1% stake. The latest purchase brings their holdings to 7.5% of the company’s outstanding shares. Fosun, which has been nibbling at Simcere for some time now, has not declared any desire to acquire Simcere, but it seems only reasonable that they will eventually seek some sort of relationship. More details....

Stock Symbols: (SHE: 600196) (NYSE: SCR)